• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内清醒小鼠大脑中苯二氮䓬受体占有率与葡萄糖代谢反应之间的非线性关系。

Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.

作者信息

Ishizuka H, Sawada Y, Ito K, Sugiyama Y, Suzuki H, Iga T, Hanano M

机构信息

Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

出版信息

J Pharmacol Exp Ther. 1989 Oct;251(1):362-7.

PMID:2552078
Abstract

To evaluate the relationship between the pharmacological effect of benzodiazepine (BZP) and BZP receptor (BZP-R) binding in the conscious mouse brain, a response of the local cerebral metabolic rate of glucose utilization (GU) to clonazepam (CNZ) was measured as an index for the pharmacological effect. Two glucose analogs (3-O-[3H]methylglucose and 2-[14C]deoxyglucose) method, originally presented by A. Gjedde was used for determination of GU. In the cerebral cortex, GU decreased to 70 to 80% at 60 min after i.v. administration of CNZ (0.005-1.0 mg/kg), but CNZ did not change the lumped constant, and this effect was diminished completely by the administration of a BZP antagonist, Ro-15-1788 (5 mg/kg). The maximum effect of CNZ on GU (about 30% decrease) was found at 0.1 mg/kg of CNZ, but increasing the dose to 1 mg/kg had very little additional effect. In vivo BZP-R occupancy was measured using [3H]-Ro-15-1788. Receptor occupancy increased from less than 10% at a dose of 0.005 mg/kg up to essentially 100% at doses of 1 mg/kg or greater. ID50 in dose-response curve of the receptor occupancy for CNZ and ED50 in that of decrease in GU were 0.3 and 0.007 mg/kg, respectively . A nonlinear and hyperbolic relationship was observed between the receptor occupancy and the response for the glucose metabolic rate, indicating that BZP exert the maximum glucose metabolic change at a low fractional receptor occupancy (30-40%).

摘要

为评估苯二氮䓬(BZP)的药理作用与清醒小鼠脑内BZP受体(BZP-R)结合之间的关系,测量了局部脑葡萄糖代谢率(GU)对氯硝西泮(CNZ)的反应,以此作为药理作用的指标。采用最初由A. 杰德德提出的两种葡萄糖类似物(3-O-[³H]甲基葡萄糖和2-[¹⁴C]脱氧葡萄糖)方法来测定GU。在大脑皮层,静脉注射CNZ(0.005 - 1.0 mg/kg)后60分钟,GU降至70%至80%,但CNZ并未改变集总常数,且给予BZP拮抗剂Ro-15-1788(5 mg/kg)后该效应完全消失。发现CNZ对GU的最大效应(约降低30%)出现在0.1 mg/kg的CNZ剂量时,但将剂量增加至1 mg/kg时,额外效应非常小。使用[³H]-Ro-15-1788测量体内BZP-R占有率。受体占有率从0.005 mg/kg剂量时的不到10%增加至1 mg/kg或更高剂量时的基本100%。CNZ受体占有率剂量反应曲线的半数抑制剂量(ID50)和GU降低曲线的半数有效剂量(ED50)分别为0.3和0.007 mg/kg。在受体占有率与葡萄糖代谢率反应之间观察到非线性双曲线关系,表明BZP在低分数受体占有率(30% - 40%)时发挥最大的葡萄糖代谢变化。

相似文献

1
Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.体内清醒小鼠大脑中苯二氮䓬受体占有率与葡萄糖代谢反应之间的非线性关系。
J Pharmacol Exp Ther. 1989 Oct;251(1):362-7.
2
Benzodiazepine receptor occupancy in vivo: correlation with brain concentrations and pharmacodynamic actions.体内苯二氮䓬受体占有率:与脑内浓度及药效学作用的相关性
J Pharmacol Exp Ther. 1987 Feb;240(2):516-22.
3
Linear relationship between GABAA receptor occupancy of muscimol and glucose metabolic response in the conscious mouse brain. Clinical implication based on comparison with benzodiazepine receptor agonist.
Drug Metab Dispos. 1994 Jan-Feb;22(1):50-4.
4
Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L-838417.啮齿动物体内GABAA受体亚型选择性苯二氮䓬位点配体L-838417的药代动力学及受体占有率
Biopharm Drug Dispos. 2005 Jan;26(1):13-20. doi: 10.1002/bdd.423.
5
In vivo binding of beta-carbolines in mice: regional differences and correlation of occupancy to pharmacological effects.
Mol Pharmacol. 1988 Aug;34(2):124-8.
6
Repeated swim stress alters brain benzodiazepine receptors measured in vivo.反复的游泳应激会改变体内测量的脑苯二氮䓬受体。
J Pharmacol Exp Ther. 1989 Jun;249(3):701-7.
7
Kinetic and dynamic components of increased benzodiazepine sensitivity in aging animals.衰老动物中苯二氮䓬敏感性增加的动力学和动态成分。
J Pharmacol Exp Ther. 1990 Jun;253(3):1153-61.
8
Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptors.体内和体外[³H]氟马西尼结合试验的比较,以确定大鼠脑γ-氨基丁酸A受体苯二氮䓬结合位点的占有率。
Neuropharmacology. 2006 Jul;51(1):168-72. doi: 10.1016/j.neuropharm.2006.03.020. Epub 2006 May 11.
9
Benzodiazepine response and receptor binding after chronic ethanol ingestion in a mouse model.小鼠模型中慢性乙醇摄入后的苯二氮䓬反应及受体结合情况
J Pharmacol Exp Ther. 1991 Sep;258(3):812-9.
10
Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.特异性结合至中枢苯二氮䓬位点对两种新型苯二氮䓬位点配体脑内浓度的贡献。
Biopharm Drug Dispos. 2007 Sep;28(6):275-82. doi: 10.1002/bdd.553.

引用本文的文献

1
Septal co-infusions of glucose with the benzodiazepine agonist chlordiazepoxide impair memory, but co-infusions of glucose with the opiate morphine do not.葡萄糖与苯二氮䓬类激动剂氯氮䓬合用注入隔核会损害记忆,但葡萄糖与阿片类药物吗啡合用注入则不会。
Physiol Behav. 2010 Mar 30;99(4):438-44. doi: 10.1016/j.physbeh.2009.12.002. Epub 2009 Dec 22.
2
Receptor occupancy in myocardium, adrenal cortex, and brain by TH-142177, a novel AT1 receptor antagonist in rats, in relation to its plasma concentration and hypotensive effect.新型AT1受体拮抗剂TH-142177在大鼠心肌、肾上腺皮质和脑中的受体占有率及其与血浆浓度和降压作用的关系。
Pharm Res. 1998 Jun;15(6):911-7. doi: 10.1023/a:1011932800729.
3
Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.
通过正电子发射断层扫描测量单次口服组胺H1拮抗剂后人类大脑中组胺H1受体占有率。
Br J Pharmacol. 1995 Sep;116(1):1649-55. doi: 10.1111/j.1476-5381.1995.tb16386.x.
4
Classification of benzodiazepine hypnotics in humans based on receptor occupancy theory.基于受体占有率理论对人类苯二氮䓬类催眠药进行分类。
J Pharmacokinet Biopharm. 1993 Feb;21(1):31-41. doi: 10.1007/BF01061774.
5
Prediction of the therapeutic dose for beta-stimulants based on preclinical data: application of oral dosage forms and aerosols to asthmatic patients.基于临床前数据预测β-兴奋剂的治疗剂量:口服剂型和气雾剂在哮喘患者中的应用。
J Pharmacokinet Biopharm. 1993 Apr;21(2):133-44. doi: 10.1007/BF01059766.